BillionToOne, Inc.

BillionToOne, Inc.BLLNEarnings & Financial Report

Nasdaq · Health Care · Services-Medical Laboratories

BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.

Insider Transactions

Net 90d: +$0 · buys $0 / sells $0
Range:
Action:
Role:
No transactions match these filters.